Kimberly Westrich, MA, is the Chief Strategy Officer of the National Pharmaceutical Council (NPC), which sponsors and conducts research on health policy issues related to the development and use of innovative biopharmaceuticals to improve the health of patients. NPC’s research contributes to the body of evidence that supports discussions and decisions about patient access to treatments, appropriate use, and the value innovative treatments provide to both patients and the health care system.
Ms. Westrich provides strategic guidance to NPC’s policy research and communications activities. She leads several research initiatives across NPC’s portfolio, including employer-sponsored insurance. She has published extensively on issues related to value assessment frameworks, patient-centered formulary and benefit design, value-based contracts, quality performance measurement, and accountable care organizations.
Ms. Westrich began her NPC career in 2000. She has also served as Director of Research at the Pharmaceutical Research and Manufacturers of America (PhRMA), worked as a healthcare consultant at The Lewin Group and Xcenda, and as a health economics and outcomes researcher at Johnson & Johnson.
Ms. Westrich is a certified yoga teacher and life coach with a passion for helping others learn and thrive. She received her master’s degree in economics from Northwestern University and her undergraduate degree in economics and mathematics from the College of William and Mary.